SUN bioscience Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 12

Employees

  • Latest Deal Type
  • M&A

SUN bioscience General Information

Description

Developer of a drug culture platform designed to deliver personalized medicine through patient-specific organoids. The company's platform uses three-dimensional miniaturized tissues to mimic organ functions that are derived from stem cells, enabling professionals to accelerate the translation of stem cell research to clinics.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • EPFL Innovation Park
  • Building D
  • 1015 Lausanne
  • Switzerland
Primary Industry
Discovery Tools (Healthcare)
Acquirer
Corporate Office
  • EPFL Innovation Park
  • Building D
  • 1015 Lausanne
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SUN bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Merger/Acquisition 17-Nov-2025 Completed Generating Revenue
16. Later Stage VC Completed Generating Revenue
15. Later Stage VC 24-Feb-2024 Completed Generating Revenue
14. Grant Completed Generating Revenue
13. Debt - General 26-May-2023 Completed Generating Revenue
12. Debt - General 13-May-2022 Completed Generating Revenue
11. Debt - General 11-May-2021 Completed Generating Revenue
10. Seed Round 19-Jan-2021 Completed Generating Revenue
9. Grant 01-Dec-2020 $118K $200K Completed Startup
8. Grant 24-Jul-2019 $30K $200K Completed Startup
To view SUN bioscience’s complete valuation and funding history, request access »

SUN bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view SUN bioscience’s complete cap table history, request access »

SUN bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug culture platform designed to deliver personalized medicine through patient-specific organoids. The c
Discovery Tools (Healthcare)
Lausanne, Switzerland
12 As of 2024

Oegstgeest, Netherlands
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SUN bioscience Competitors (6)

One of SUN bioscience’s 6 competitors is MIMETAS, a Venture Capital-Backed company based in Oegstgeest, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MIMETAS Venture Capital-Backed Oegstgeest, Netherlands
Okomera Venture Capital-Backed Paris, France
Kugelmeiers Private Equity-Backed Erlenbach, Switzerland
Emulate Venture Capital-Backed Boston, MA
InSphero Private Equity-Backed Schlieren, Switzerland
To view SUN bioscience’s complete competitors history, request access »

SUN bioscience Patents

SUN bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-7318156-B2 Biomaterial culture wells Active 30-May-2018
CA-3102043-A1 Well for cultivating biological material Pending 30-May-2018
EP-3802776-A1 Well for cultivating biological material Pending 30-May-2018
WO-2019229545-A1 Well for cultivating biological material Inactive 30-May-2018
JP-2021525096-A Wells for culturing biomaterials Active 30-May-2018 C12M23/12
To view SUN bioscience’s complete patent history, request access »

SUN bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SUN bioscience Former Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Acequia Capital Venture Capital Minority
Cartier Women's Initiative Corporation Minority
Centre Suisse Delectronique et de Microtechnique Not-For-Profit Venture Capital Minority
EIT Health Accelerator/Incubator
Ecole Polytechnique Federale de Lausanne University Minority
You’re viewing 5 of 15 investors. Get the full list »

SUN bioscience FAQs

  • When was SUN bioscience founded?

    SUN bioscience was founded in 2016.

  • Where is SUN bioscience headquartered?

    SUN bioscience is headquartered in Lausanne, Switzerland.

  • What is the size of SUN bioscience?

    SUN bioscience has 12 total employees.

  • What industry is SUN bioscience in?

    SUN bioscience’s primary industry is Discovery Tools (Healthcare).

  • Is SUN bioscience a private or public company?

    SUN bioscience is a Private company.

  • What is SUN bioscience’s current revenue?

    The current revenue for SUN bioscience is .

  • How much funding has SUN bioscience raised over time?

    SUN bioscience has raised $5.11M.

  • Who are SUN bioscience’s investors?

    Acequia Capital, Cartier Women's Initiative, Centre Suisse Delectronique et de Microtechnique, EIT Health, and Ecole Polytechnique Federale de Lausanne are 5 of 15 investors who have invested in SUN bioscience.

  • Who are SUN bioscience’s competitors?

    MIMETAS, Okomera, Kugelmeiers, Emulate, and InSphero are some of the 6 competitors of SUN bioscience.

  • When was SUN bioscience acquired?

    SUN bioscience was acquired on 17-Nov-2025.

  • Who acquired SUN bioscience?

    SUN bioscience was acquired by InSphero.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process